Effect of Zoledronate on Bone Mineral Density and Bone Turnover Markers after Long-term Denosumab Therapy: Observations in a Real-World SettingJ. Everts-Graber,S. Reichenbach,B. Gahl, H. J. Hauselmann,H. R. Ziswiler, U. Studer,T. LehmannSWISS MEDICAL WEEKLY(2022)引用 0|浏览5暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要